Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-12-7
pubmed:abstractText
Radioligand binding of the opioid receptor subtype selective ligands, [3H][D-Ala2,N-Me-Phe4, Gly-ol5]-enkephalin (DAMGO) (mu), [3H][D-Pen2,D-Pen5]-enkephalin (DPDPE) (delta) and [3H]U-69,593 (kappa), to rat brain particulate preparations was virtually unaffected by 1-100 microM glibenclamide (Glib) or tetraethylammonium bromide (TEA). These results argue against opioid receptor antagonism by Glib or TEA and support the hypothesis that antagonism of opioid-induced antinociception by Glib or TEA occurs at the level of K+ (possibly ATP-sensitive KATP) channels.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0006-8993
pubmed:author
pubmed:issnType
Print
pubmed:day
4
pubmed:volume
650
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
146-8
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Lack of glibenclamide or TEA affinity for opioid receptors: further evidence for in vivo modulation of antinociception at K+ channels.
pubmed:affiliation
R. W. Johnson Pharmaceutical Research Institute, Spring House, PA 19477-0776.
pubmed:publicationType
Journal Article